Trials / Completed
CompletedNCT07001553
Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study
Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Australian Catholic University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
Detailed description
Forty individuals (20 for weight management, 20 for diabetes management) living in Australia who have been prescribed a GLP-1 agonist (no previous prescription or no use in the previous 6 months) will be recruited to participate over the initial 3 months of their treatment. Assessments will occur remotely (online) at baseline, 2 weeks, 1 month and 3 months. Optional body composition assessments will be provided at baseline and 3 months for those based in Melbourne, Australia.
Conditions
Timeline
- Start date
- 2025-05-28
- Primary completion
- 2026-01-07
- Completion
- 2026-01-07
- First posted
- 2025-06-03
- Last updated
- 2026-03-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07001553. Inclusion in this directory is not an endorsement.